PROSPECTS AND OPPORTUNITIES
CBD based products could see good growth over the forecast period
CBD based products have the potential to see significant growth in the Israeli market over the forecast period, provided that they are marketed correctly, as consumers are seeking more natural products to combat pain. Much will depend on how well received Cannasen is in Israel, and it will be interesting to see if this product becomes very popular or if it suffers from a lack of consumer information or negative beliefs about CBD consumption.
Old favourites likely to lead market into the future
Amongst analgesics brands, well-established consumer favourites, Acamol, Decamol and Optalgin are likely to lead the market over the foreseeable future as people know and trust these brands. In addition, these brands are widely available both online and in pharmacies and have a good reputation in the country, which will continue to stimulate sales.
Israel-Hamas war likely to have ongoing effect on pain relief sales
With the Israel-Hamas war ongoing, it is likely that an increasing number of adults and children will seek out products from the analgesics (systemic) and topical analgesics/anaesthetic categories to grapple with tension headaches and other types of tension related pain in the early part of the forecast period. In addition, the economic downturn seen in the early part of 2024 is likely to mean that people will continue to use private label products, as well as turning to larger packs that may be discounted in order to save money, which will constrain value growth in the analgesics category.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the Analgesics industry in Israel with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Analgesics industry in Israel, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The Analgesics in Israel report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of Analgesics in Israel?
- Which are the leading brands in Analgesics in Israel?
- How are products distributed in Analgesics in Israel?
- How has the regulatory and operating environment for Analgesics changed in Israel?
- How are considerations such as stress, self-medication and shifting consumer lifestyles shaping demand for Analgesics
- How significant are wider health concerns and consumer awareness in determining sales?
- Where is future growth expected to be most dynamic?
Analgesics in Israel - Category analysis
KEY DATA FINDINGS
People demand more pain relief in 2024 due to stress of Israel-Hamas war
Consumers become interested in more natural variants to analgesics
A few players dominate the competitive landscape
CBD based products could see good growth over the forecast period
Old favourites likely to lead market into the future
Israel-Hamas war likely to have ongoing effect on pain relief sales
Consumer Health in Israel - Industry Overview
Consumer health in 2024: The big picture
2024 key trends
Competitive landscape
Retailing developments
What next for consumer health?
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
The following categories and subcategories are included:
Analgesics
-
-
- Adult Acetaminophen
- Adult Aspirin
- Adult Combination Products - Analgesics
- Adult Diclofenac
- Adult Dipyrone
- Adult Ibuprofen
- Adult Ketoprofen
- Adult Naproxen
- Adult OTC Triptans
-
- Paediatric Acetaminophen
- Paediatric Aspirin
- Paediatric Combination Products - Analgesics
- Paediatric Dipyrone
- Paediatric Ibuprofen
- Paediatric Naproxen
-
- Acetaminophen
- Aspirin
- Combination Products - Analgesics
- Diclofenac
- Dipyrone
- Ibuprofen
- Ketoprofen
- Naproxen
- OTC Triptans
-
- Topical Analgesics/Anaesthetic
Analgesics
Analgesics cover systemic and topical pain relievers. Products which include a pain-relief ingredient in addition to another core function are excluded (e.g. a sore throat remedy which includes paracetamol is excluded from the analgesics and instead is included in pharyngeal remedies).
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our Analgesics research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!